home All News open_in_new Full Article

Experimental drug helps patients lose nearly a quarter of body weight in early trials

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.


today 11 h. ago attach_file Politics

attach_file Politics
attach_file Science
attach_file Events
attach_file Events
attach_file Events
attach_file Science
attach_file Politics


ID: 2567684752
Add Watch Country

arrow_drop_down